A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)
Clinical trial NCT01369355 · COMPLETED
Trial details
- NCT number
- NCT01369355
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-13
- Primary completion
- 2015-06-10
- Enrollment
- 1282
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.